Status: current, Primitive. Date: 31-Jan 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3533457018 | Tivozanib (substance) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 3533458011 | Tivozanib | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Tivozanib | Is a | Antineoplastic agent | true | Inferred relationship | Some | ||
| Tivozanib | Is a | Quinoline | true | Inferred relationship | Some | ||
| Tivozanib | Has disposition | Protein-tyrosine kinase inhibitor | true | Inferred relationship | Some | ||
| Tivozanib | Is a | Protein-tyrosine kinase inhibitor | true | Inferred relationship | Some | ||
| Tivozanib | Is a | Enzyme inhibitor | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Tivozanib only product | Has active ingredient | True | Tivozanib | Inferred relationship | Some | 1 |
| Tivozanib only product in oral dose form | Has active ingredient | True | Tivozanib | Inferred relationship | Some | 1 |
| Tivozanib hydrochloride | Is modification of | True | Tivozanib | Inferred relationship | Some | |
| Tivozanib (as tivozanib hydrochloride) 890 microgram oral capsule | Has BoSS | True | Tivozanib | Inferred relationship | Some | 1 |
| Tivozanib (as tivozanib hydrochloride) 1.34 mg oral capsule | Has BoSS | True | Tivozanib | Inferred relationship | Some | 1 |
| Tivozanib-containing product | Has active ingredient | True | Tivozanib | Inferred relationship | Some | 1 |
| Tivozanib-containing product in oral dose form | Has active ingredient | True | Tivozanib | Inferred relationship | Some | 1 |
Reference Sets
Substance foundation reference set
FHIR